Monaco Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Monaco Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-125,000	Closed	-$1.41M	–	88
2025 Q2	$1.41M	Sell	125,000 -52,500	-30%	-$407K	0.25%	55
2025 Q1	$1.01M	Sell	177,500 -207,164	-54%	-$2.11M	0.21%	51
2024 Q4	$3.78M	Buy	384,664 +14,539	+4%	+$125K	0.55%	27
2024 Q3	$3.02M	Buy	370,125 +125,125	+51%	+$1.25M	0.44%	40
2024 Q2	$3.28M	Buy	+245,000	New	+$7.31M	0.52%	25

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Monaco Asset Management's DNA Position: Q3 2025 in Review

Monaco Asset Management sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 125,000 shares — an estimated $1.41M sold.

Monaco Asset Management first reported a position in DNA in Q2 2024 and held it in 5 quarters. The position peaked at $3.78M in Q4 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

Monaco Asset Management reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
Monaco Asset Management sold 125,000 Ginkgo Bioworks shares in Q3 2025, an estimated $1.41M.
Monaco Asset Management first reported a position in Ginkgo Bioworks in Q2 2024 and held it in 5 quarters.
Monaco Asset Management's Ginkgo Bioworks position peaked at $3.78M in Q4 2024.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on Monaco Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.